Design Therapeutics Inc (DSGN)

SG&A Expense Growth

12.78%

Fiscal year · Period ending:

DSGN logo

DSGN SG&A Expense Growth

Latest reported12.78%
DSGN FY SG&A Growth (YoY) (0.00% → 12.78%)
High-resolution chart · PNG

DSGN sg&a expense growth history

Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years.

Design Therapeutics Inc SG&A Expense Growth — Annual fiscal periods
Period endingSG&A Expense Growth
12.7821%
-14.6448%
11.3119%
71.7181%
342.8285%
129.4118%
0%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.